The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 1.78x ...

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December ...

Ahead of the IPO, Senores Pharmaceuticals on Thursday, 19 December 2024, raised Rs 260.62 crore from anchor investors. The board allotted 66.65 lakh shares at Rs 391 each to 20 anchor investors.

Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

Senores Pharmaceuticals Ltd. opened for day two of subscription on Monday. The Rs 582.11-crore offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.11 crore. It has been ...

According to stock market observers, shares of the company are available at a premium of ₹191 in the grey market today ...

The Initial Public Offering of Senores Pharmaceuticals Limited was fully subscribed on the first day of bidding.

Proceeds from the fresh issue will be used for setting up a manufacturing facility for production of sterile injections in ...

Senores Pharmaceuticals Limited raised ₹261 crore from its anchor investors ahead of its public issue. The IPO is set to open ...

Senores Pharma IPO opens today, December 20, 2024, and closes for subscription on December 24, 2024. Check issue size, price ...

Senores Pharmaceuticals IPO's last GMP is Rs 150 as of 1:25 p.m. on Dec. 19, according to InvestorGain. This implies shares ...